The Bitter Fate of the Sweet Heart: Impairment of Iron Homeostasis in Diabetic Heart Leads to Failure in Myocardial Protection by Preconditioning

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Vinokur, Vladimir ^a,b   Berenshtein, Eduard ^a   Bulvik, Baruch ^a   Grinberg, Leonid ^a   Eliashar, Ron ^b   Chevion, Mordechai ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; MESSENGER RNA; PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART PROTECTION; IRON BALANCE; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; PROTEIN DEGRADATION; RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FERRITINS; HEART; HOMEOSTASIS; IRON; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIUM; POLYMERASE CHAIN REACTION; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STREPTOZOCIN;

EID: 84877757087     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062948     Document Type: Article

References (44)

1. Blonde L, Dempster J, Gallivan JM, Warren-Boulton E, (2006) Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program. J Am Acad Nurse Pract 18: 524-533.
2. Rezkalla SH, Kloner RA, (2004) Ischemic preconditioning and preinfarction angina in the clinical arena. Nat Clin Pract Cardiovasc Med 1: 96-102.
3. Schwarz ER, Reffelmann T, Kloner RA, (1999) Clinical effects of ischemic preconditioning. Curr Opin Cardiol 14: 340-348.
4. Tani M, Neely JR, (1988) Hearts from diabetic rats are more resistant to in vitro ischemia: possible role of altered Ca2+ metabolism. Circ Res 62: 931-940.
5. Evans JM, Wang J, Morris AD, (2002) Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. Bmj 324: 939-942.
6. Hearse DJ, Stewart DA, Chain EB, (1975) Diabetes and the survival and recovery of the anoxic myocardium. J Mol Cell Cardiol 7: 397-415.
7. Vinokur V, Leibowitz G, Grinberg L, Eliashar R, Berenshtein E, et al. (2007) Diabetes and the heart: could the diabetic myocardium be protected by preconditioning? Redox Rep 12: 246-256.
8. Hassouna A, Loubani M, Matata BM, Fowler A, Standen NB, et al. (2006) Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovasc Res 69: 450-458.
9. Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC, (2000) Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 278: H1218-1224.
10. Monteiro P, Goncalves L, Providencia LA, (2005) Diabetes and cardiovascular disease: the road to cardioprotection. Heart 91: 1621-1625.
11. Chevion M, Jiang Y, Har El R, Berenshtein E, Uretzky G, et al. (1993) Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. Proc Natl Acad Sci U S A 90: 1102-1106.
12. Berenshtein E, Mayer B, Goldberg C, Kitrossky N, Chevion M, (1997) Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury. J Mol Cell Cardiol 29: 3025-3034.
13. Berenshtein E, Vaisman B, Goldberg-Langerman C, Kitrossky N, Konijn AM, et al. (2002) Roles of ferritin and iron in ischemic preconditioning of the heart. Mol Cell Biochem 234-235: 283-292.
14. Hicks KK, Seifen E, Stimers JR, Kennedy RH, (1997) Diabetes with and without ketoacidosis on right atrial pacemaker rate and autonomic responsiveness. Am J Physiol 273: H1888-1893.
15. Mensah K, Mocanu MM, Yellon DM, (2005) Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? J Am Coll Cardiol 45: 1287-1291.
16. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, et al. (1981) Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 101: 593-600.
17. Ytrehus K, Liu Y, Tsuchida A, Miura T, Liu GS, et al. (1994) Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol 267: H2383-2390.
18. Vaisman B, Santambrogio P, Arosio P, Fibach E, Konijn AM, (1999) An ELISA for the H-subunit of human ferritin which employs a combination of rabbit poly- and mice monoclonal antibodies and an enzyme labeled anti-mouse-IgG. Clin Chem Lab Med 37: 121-125.
19. Nilsson UA, Bassen M, Savman K, Kjellmer I, (2002) A simple and rapid method for the determination of "free" iron in biological fluids. Free Radic Res 36: 677-684.
20. Reno C, Marchuk L, Sciore P, Frank CB, Hart DA, (1997) Rapid isolation of total RNA from small samples of hypocellular, dense connective tissues. Biotechniques 22: 1082-1086.
21. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
22. Malone MA, Schocken DD, Hanna SK, Liang X, Malone JI, (2007) Diabetes-induced bradycardia is an intrinsic metabolic defect reversed by carnitine. Metabolism 56: 1118-1123.
23. Chevion M, Leibowitz S, Nu Nu A, Novogrodsky O, Singer A, et al. (2008) Heart Protection by Ischemic Preconditioning: A Novel Pathway Initiated by Iron and Mediated by Ferritin. J Mol Cell Cardiol (in press).
24. Hayden JM, Reaven PD, (2000) Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors. Curr Opin Lipidol 11: 519-528.
25. Goldberg IJ, (2004) Why does diabetes increase atherosclerosis? I don't know! J Clin Invest 114: 613-615.
26. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, et al. (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96: 1395-1403.
27. Ravingerova T, Stetka R, Volkovova K, Pancza D, Dzurba A, et al. (2000) Acute diabetes modulates response to ischemia in isolated rat heart. Mol Cell Biochem 210: 143-151.
28. Chen H, Shen WL, Wang XH, Chen HZ, Gu JZ, et al. (2006) Paradoxically enhanced heart tolerance to ischaemia in type 1 diabetes and role of increased osmolarity. Clin Exp Pharmacol Physiol 33: 910-916.
29. Liu Y, Thornton JD, Cohen MV, Downey JM, Schaffer SW, (1993) Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation 88: 1273-1278.
30. Hadour G, Ferrera R, Sebbag L, Forrat R, Delaye J, et al. (1998) Improved myocardial tolerance to ischaemia in the diabetic rabbit. J Mol Cell Cardiol 30: 1869-1875.
31. Lenk SE, Bhat D, Blakeney W, Dunn WA Jr, (1992) Effects of streptozotocin-induced diabetes on rough endoplasmic reticulum and lysosomes of rat liver. Am J Physiol 263: E856-862.
32. Marfella R, Cacciapuoti F, Grassia A, Manfredi E, De Maio G, et al. (2006) Role of the ubiquitin-proteasome system in carotid plaque instability in diabetic patients. Acta Cardiol 61: 630-636.
33. Marfella R, Di Filippo C, Portoghese M, Siniscalchi M, Martis S, et al. (2009) The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control. Cardiovasc Pathol 18: 332-345.
34. Cairo G, Tacchini L, Pogliaghi G, Anzon E, Tomasi A, et al. (1995) Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool. J Biol Chem 270: 700-703.
35. Stefanini S, Chiancone E, Arosio P, Finazzi-Agro A, Antonini E, (1982) Structural heterogeneity and subunit composition of horse ferritins. Biochemistry 21: 2293-2299.
36. Collawn JF Jr, Fish WW, (1984) The distribution of ferritin subunit types in porcine tissues. Comp Biochem Physiol B 78: 653-656.
37. Fert-Bober J, Basran RS, Sawicka J, Sawicki G, (2008) Effect of duration of ischemia on myocardial proteome in ischemia/reperfusion injury. Proteomics 8: 2543-2555.
38. Giordani A, Haigle J, Leflon P, Risler A, Salmon S, et al. (2000) Contrasting effects of excess ferritin expression on the iron-mediated oxidative stress induced by tert-butyl hydroperoxide or ultraviolet-A in human fibroblasts and keratinocytes. J Photochem Photobiol B 54: 43-54.
39. Elia G, Polla B, Rossi A, Santoro MG, (1999) Induction of ferritin and heat shock proteins by prostaglandin A1 in human monocytes. Evidence for transcriptional and post-transcriptional regulation. Eur J Biochem 264: 736-745.
40. Rothfuss A, Speit G, (2002) Investigations on the mechanism of hyperbaric oxygen (HBO)-induced adaptive protection against oxidative stress. Mutat Res 508: 157-165.
41. Merforth S, Osmers A, Dahlmann B, (1999) Alterations of proteasome activities in skeletal muscle tissue of diabetic rats. Mol Biol Rep 26: 83-87.
42. Zeltcer G, Berenshtein E, Kitrossky N, Chevion M, Samuni A, (2002) Time window of nitroxide effect on myocardial ischemic-reperfusion injury potentiated by iron. Free Radic Biol Med 32: 912-919.
43. Zeltcer G, Berenshtein E, Samuni A, Chevion M, (1997) Nitroxide radicals prevent metal-aggravated reperfusion injury in isolated rat heart. Free Radic Res 27: 627-635.
44. Mastrogiannaki M, Matak P, Keith B, Simon MC, Vaulont S, et al. (2009) HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest 119: 1159-1166.